arrow
T

Tobias Reichlin

university of chicago
H指数:70
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and Efficacy of Left Atrial Ablation After Percutaneous Left Atrial Appendage Occlusion in High-Bleeding-Risk Patients with Atrial Fibrillation: A Multicenter Analysis from the PROCEED-AF Ablation Registry

心房颤动高危出血风险患者经皮左心耳封堵术后行左心房消融的安全性和有效性:来自PROCEED-AF消融登记研究的多中心分析

2026-09-250
OAAI
Rhythm-Guided Pill-in-the-Pocket Anticoagulation Following Cryoballoon Ablation: A COMPARE-CRYO post-hoc analysis

节律指导下的口袋式抗凝疗法在冷冻球囊消融后的应用:COMPARE-CRYO研究的回顾性分析

2026-09-160
OAAI
Intracardiac Echocardiography and Coronary Angiography During Ventricular Ablation From the Aortic Cusps and Commissures: Marked Inter-Center Variability Without an Observed Coronary Injury Signal

经心腔超声心动图和冠状动脉造影在主动脉瓣瓣叶和交界处室性消融术中的应用:显著的中心间差异,未观察到冠状动脉损伤信号

2026-05-010
OAAI
Pulsed Field Ablation for the Interventional Treatment of Atrial Fibrillation. A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS) and the Canadian Heart Rhythm Society (CHRS)

脉冲场消融用于心房颤动的介入治疗。欧洲心律学会(EHRA)的ESC、心律学会(HRS)、亚太心律学会(APHRS)、拉丁美洲心律学会(LAHRS)和加拿大心律学会(CHRS)的科学声明

2026-04-120
PRE
Characteristics, pathophysiological mechanisms and ablation outcomes of patients with de-novo left atrial flutter compared to patients with post-ablation left atrial flutter

特发性左心房扑动与术后左心房扑动患者的特征、病理生理机制及消融结局的比较

2026-03-270
OAAI
Adverse outcomes in patients with atrial fibrillation and a pacemaker: a cohort study

心房颤动合并起搏器患者的不良结局:一项队列研究

2025-11-010
OAAI
Safety and effectiveness of left atrial appendage occlusion in patients with atrial fibrillation and high bleeding risk: a cardinality-matched comparison with direct oral anticoagulation on long-term stroke and bleeding rates

心房颤动伴高出血风险患者左心耳封堵的安全性与有效性:与直接口服抗凝剂在长期卒中及出血率方面的基数匹配比较

2025-10-010
OAAI
Impact of alternative efficacy endpoint definitions on reported outcomes after ablation of paroxysmal atrial fibrillation – insights from the COMPARE-CRYO study using continuous rhythm monitoring

房颤导管消融术后替代疗效终点定义对报告结局的影响——来自使用连续心律监测的COMPARE-CRYO研究的见解

2025-09-190
OAAI
Safety and efficacy of a lattice-tip catheter for ventricular arrhythmia ablation: the AFFERA Ventricular Arrhythmia Ablation Registry (AVAAR)

网状尖端导管在室性心律失常消融中的安全性和有效性:Affera Ventricular Arrhythmia Ablation (AVAAR) 注册研究

2025-09-013
OAAI
Atrial fibrillation and atherosclerosis cause different vascular brain lesions on magnetic resonance imaging

房颤和动脉粥样硬化导致磁共振成像上不同的血管性脑损伤。

2025-08-012
PRE
Repeat procedures after pulsed field ablation for atrial fibrillation: MANIFEST-REDO study

心房颤动经脉冲场消融后的重复程序:<i>MANIFEST-REDO</i> 研究

2025-08-0117
OA
Biomarker panels for improved risk prediction and enhanced biological insights in patients with atrial fibrillation

房颤患者中用于改善风险预测和增强生物学见解的生物标志物组合

2025-07-310
OAAI
Colchicine in patients with aortic stenosis undergoing transcatheter aortic valve replacement: a double-blind randomized trial

秋水仙碱在主动脉瓣狭窄患者经导管主动脉瓣置换术中的应用: 一项双盲随机试验

2025-07-150
OAAI
Biomarker and cognitive decline in atrial fibrillation: a prospective cohort study

心房颤动的生物标志物和认知下降: 一项前瞻性队列研究

2025-04-150
OAAI
The Association of Heart Failure and Liver T1 Mapping in Cardiac Magnetic Resonance Imaging
2025-03-200
OAAI
Dose-dependent ventricular lesion formation using a novel large-area pulsed field ablation catheter: A preclinical feasibility study

剂量依赖性心室病变形成:一种新型大面积脉冲场消融导管的应用——一项临床前可行性研究

2025-02-110
PREAI